ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000158352 | SHROOM4 | Shroom family member 4 | [
"Q9ULL8"
] | X | 50586796-50814302 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA010089",
"HPA010565"
] | [
"KIAA1202"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding",
"Developmental protein"
] | [
"Intellectual disability"
] | [
"Focal adhesion sites"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 30: White matter - Myelination | Cluster 69: Skin cancer - ECM organization | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,043 | 4 |
ENSG00000158373 | H2BC5 | H2B clustered histone 5 | [
"P58876"
] | 6 | 26158122-26171349 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042205",
"HPA043013",
"HPA048671",
"CAB062336"
] | [
"H2B/b",
"H2BFB",
"HIST1H2BD"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Supported | null | 79 | null | Yes | Cluster 24: Non-specific - Transcription | Cluster 55: Non-specific - Transcription | Cluster 41: Non-specific - Nucleosome assembly | Cluster 65: Non-specific - Cell growth & division | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 10,044 | 9 |
ENSG00000158402 | CDC25C | Cell division cycle 25C | [
"P30307"
] | 5 | 138285269-138338355 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003800",
"HPA066991"
] | [
"CDC25",
"PPP1R60"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Host-virus interaction",
"Mitosis"
] | [
"Hydrolase",
"Protein phosphatase"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [] | [] | [] | Supported | Approved | null | 55 | No | Yes | null | null | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 27: Non-specific - Cell proliferation | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 4 | 4 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,045 | 7 |
ENSG00000158406 | H4C8 | H4 clustered histone 8 | [
"P62805"
] | 6 | 26277609-26285638 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042201"
] | [
"H4/h",
"H4FH",
"HIST1H4H"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [] | [
"DNA-binding"
] | [
"Disease variant",
"Intellectual disability"
] | [] | [] | [] | [] | null | Supported | null | 62 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 35: Non-specific - DNA binding | Cluster 41: Non-specific - Nucleosome assembly | Cluster 65: Non-specific - Cell growth & division | Cluster 63: Non-specific - Basic cellular processes | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 7 | 0 | 0 | 0 | [] | [] | [] | 10,046 | 4 |
ENSG00000158411 | MITD1 | Microtubule interacting and trafficking domain containing 1 | [
"Q8WV92"
] | 2 | 99161427-99181058 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036162",
"HPA036163"
] | [
"LOC129531"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Transport"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Enhanced | Approved | null | 15 | null | null | Cluster 18: Non-specific - Translation | Cluster 11: White matter - Signal transduction | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 7: Non-specific - Transcription | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 10,047 | 1 |
ENSG00000158417 | EIF5B | Eukaryotic translation initiation factor 5B | [
"O60841"
] | 2 | 99337371-99401326 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034648",
"HPA040095"
] | [
"DKFZp434I036",
"FLJ10524",
"IF2",
"KIAA0741"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Protein biosynthesis"
] | [
"Hydrolase",
"Initiation factor"
] | [] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 16 | null | Yes | Cluster 3: Non-specific - Nuclear processes | Cluster 6: Non-specific - Immune response | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 17: Non-specific - RNA processing | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,048 | 6 |
ENSG00000158423 | RIBC1 | RIB43A domain with coiled-coils 1 | [
"Q8N443"
] | X | 53422690-53431120 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001150"
] | [
"FLJ32783"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear bodies"
] | [] | [] | [] | Approved | null | null | 45 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 3: Choroid plexus - Cilium | Cluster 27: Breast cancer - Unknown function | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in single | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Squamous Cell Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Squamous Cell Carcinoma"
] | 10,049 | 7 |
ENSG00000158427 | TMSB15B | Thymosin beta 15B | [
"P0CG35"
] | X | 103918896-103966712 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA064607"
] | [
"MGC39900"
] | [
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 2: Neurons - Nucleosome | Cluster 10: Ciliated cells - Ion channel activity | Cluster 76: Pancreatic endocrine cells - Endocrine signaling | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Skin Cutaneous Melanoma"
] | [
"Skin Cutaneous Melanoma"
] | 10,050 | 7 |
ENSG00000158428 | CATIP | Ciliogenesis associated TTC17 interacting protein | [
"Q7Z7H3"
] | 2 | 218356857-218368099 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044818"
] | [
"C2orf62",
"MGC50811"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cilium biogenesis/degradation"
] | [] | [
"Disease variant"
] | [
"Connecting piece"
] | [
"Mid piece"
] | [] | [] | Approved | Supported | null | 14 | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 34: Testis cancer - Unknown function | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 10,051 | 2 |
ENSG00000158435 | CNOT11 | CCR4-NOT transcription complex subunit 11 | [
"Q9UKZ1"
] | 2 | 101252886-101270316 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA069823",
"HPA074943"
] | [
"C2orf29",
"C40"
] | [
"Predicted intracellular proteins"
] | [
"RNA-mediated gene silencing",
"Transcription",
"Transcription regulation",
"Translation regulation"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 58 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 50: Non-specific - Nucleic acid binding | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 52: Glandular & Luminal cells - Estrogen-regulated epithelial secretion | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,052 | 5 |
ENSG00000158445 | KCNB1 | Potassium voltage-gated channel subfamily B member 1 | [
"Q14721"
] | 20 | 49293394-49484297 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001979",
"HPA042434"
] | [
"Kv2.1"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Exocytosis",
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [
"Disease variant",
"Epilepsy",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | 8 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enriched | Detected in many | 6 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,053 | 9 |
ENSG00000158457 | TSPAN33 | Tetraspanin 33 | [
"Q86UF1"
] | 7 | 129144707-129169699 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020357"
] | [
"MGC50844",
"Penumbra"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [
"Microtubules"
] | [] | [] | [] | Approved | Enhanced | null | 47 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 55: Lymphoma - Immune response | Cluster 47: Platelets - Hemostasis | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enriched | Detected in many | 6 | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,054 | 5 |
ENSG00000158458 | NRG2 | Neuregulin 2 | [
"O14511"
] | 5 | 139846779-140043299 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038935",
"HPA047973"
] | [
"Don-1",
"HRG2",
"NTAK"
] | [
"Cancer-related genes",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [
"Growth factor"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [
"Secreted in other tissues"
] | [
"Growth factor"
] | Supported | Approved | null | 3 | No | null | null | Cluster 15: Non-specific - Transcription | Cluster 51: Myeloma - Immunoglobulins | Cluster 82: Dendritic cells - Antigen presentation | Cluster 64: Non-specific - Transcription | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,055 | 3 |
ENSG00000158467 | AHCYL2 | Adenosylhomocysteinase like 2 | [
"Q96HN2"
] | 7 | 129225030-129430211 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053128"
] | [
"ADOHCYASE3",
"IRBIT2",
"KIAA0828",
"long-IRBIT"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"One-carbon metabolism"
] | [
"Hydrolase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | Approved | Uncertain | null | 12 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 36: Choroid plexus - Mixed function | Cluster 21: Lymphoma - Adaptive immune response | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 1: Choroid plexus - Transmembrane transport | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 3 | 2 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 10,056 | 5 |
ENSG00000158470 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | [
"O43286"
] | 20 | 49632945-49713878 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA077777"
] | [
"beta4GalT-V"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Sphingolipid metabolism"
] | [
"Glycosyltransferase",
"Transferase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | null | null | 15 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 1: Neurons - Mixed function | Cluster 62: Non-specific - Plasma proteins | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,057 | 8 |
ENSG00000158473 | CD1D | CD1d molecule | [
"P15813"
] | 1 | 158178030-158186427 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016107",
"HPA072662"
] | [] | [
"Cancer-related genes",
"CD markers",
"Predicted membrane proteins"
] | [
"Immunity",
"Innate immunity"
] | [] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Enhanced | null | null | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 8: Immune cells - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 6 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 10,058 | 3 |
ENSG00000158477 | CD1A | CD1a molecule | [
"P06126"
] | 1 | 158254424-158258269 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000009",
"HPA010734"
] | [
"CD1"
] | [
"CD markers",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | Cluster 2: Dendritic cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 82: Dendritic cells - Antigen presentation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 12 | Cancer enriched | Detected in single | 16 | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 4 | Group enriched | Detected in some | 25 | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 10,059 | 5 |
ENSG00000158481 | CD1C | CD1c molecule | [
"P29017"
] | 1 | 158289923-158294774 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA068359"
] | [
"CD1"
] | [
"CD markers",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Golgi apparatus",
"Vesicles"
] | [
"Endoplasmic reticulum"
] | [] | [] | Approved | null | null | 2 | null | null | Cluster 2: Dendritic cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 82: Dendritic cells - Antigen presentation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in many | 11 | Group enriched | Detected in some | 46 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 15 | Group enriched | Detected in many | 4 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,061 | 9 |
ENSG00000158485 | CD1B | CD1b molecule | [
"P29016"
] | 1 | 158327951-158331531 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA021824"
] | [
"CD1"
] | [
"CD markers",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Golgi apparatus",
"Vesicles"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 21 | null | null | Cluster 2: Dendritic cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 82: Dendritic cells - Antigen presentation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 155 | Cancer enriched | Detected in single | 487 | Low cancer specificity | Detected in some | null | Cell type enriched | Detected in some | 17 | Immune cell enriched | Detected in some | 6 | 0 | 0 | 0 | [] | [] | [] | 10,062 | 7 |
ENSG00000158486 | DNAH3 | Dynein axonemal heavy chain 3 | [
"Q8TD57"
] | 16 | 20933111-21159441 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA056212",
"HPA062493"
] | [
"DKFZp434N074",
"DLP3",
"Dnahc3b",
"Hsadhc3"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Motor protein"
] | [] | [
"Mid piece",
"Principal piece"
] | [
"Equatorial segment",
"Flagellar centriole"
] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 46: Brainstem - Mixed function | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Group enriched | Detected in some | 5 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,063 | 7 |
ENSG00000158488 | CD1E | CD1e molecule | [
"P15812"
] | 1 | 158353696-158357553 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA057769",
"HPA070634"
] | [] | [
"CD markers",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Golgi apparatus"
] | [
"Nucleoli"
] | [
"Intracellular and membrane"
] | [
"Immunity"
] | Supported | Uncertain | null | null | null | null | Cluster 2: Dendritic cells - Unknown function | null | Cluster 59: Leukemia - T-cell receptor | Cluster 82: Dendritic cells - Antigen presentation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in many | 68 | Cancer enriched | Detected in single | 433 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 9 | Immune cell enriched | Detected in some | 14 | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,064 | 3 |
ENSG00000158497 | HMHB1 | Histocompatibility minor HB-1 | [
"O97980"
] | 5 | 143812161-143820716 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"HB-1",
"HB-1Y"
] | [
"Predicted intracellular proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | null | Cluster 35: RS4;11 - Unknown function | Cluster 77: Late primary spermatocytes - Spermiogenesis: Golgi Phase | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 28 | Not detected | Not detected | null | Cell type enriched | Detected in single | 6 | Immune cell enriched | Detected in single | 25 | 0 | 0 | 0 | [] | [] | [] | 10,065 | 1 |
ENSG00000158516 | CPA2 | Carboxypeptidase A2 | [
"P48052"
] | 7 | 130266863-130289798 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020342",
"HPA021317"
] | [] | [
"Enzymes",
"Metabolic proteins",
"Predicted secreted proteins"
] | [] | [
"Carboxypeptidase",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [] | [
"Golgi apparatus"
] | [] | [
"Secreted to digestive system"
] | [
"Enzyme"
] | Approved | Enhanced | null | 1 | null | null | null | Cluster 30: White matter - Myelination | Cluster 66: Non-specific - Mitochondria | Cluster 5: Pancreatic acinar cells - Pancreatic exocrine secretion | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in many | 417 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 48 | Cell type enriched | Detected in some | 32 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 10,066 | 9 |
ENSG00000158517 | NCF1 | Neutrophil cytosolic factor 1 | [
"P14598"
] | 7 | 74774011-74789315 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004524",
"HPA047836",
"HPA052095"
] | [
"NCF1A",
"NOXO2",
"p47phox",
"SH3PXD1A"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Chronic granulomatous disease",
"Disease variant"
] | [] | [] | [] | [] | null | Enhanced | null | 37 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 25: Non-specific - Transcription | Cluster 55: Lymphoma - Immune response | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 5 | Group enriched | Detected in all | 5 | 0 | 0 | 0 | [] | [] | [] | 10,067 | 2 |
ENSG00000158525 | CPA5 | Carboxypeptidase A5 | [
"Q8WXQ8"
] | 7 | 130344816-130368730 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA020322"
] | [] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Carboxypeptidase",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [] | [
"Nucleoplasm"
] | [] | [
"Secreted in male reproductive system"
] | [
"Enzyme"
] | Approved | null | null | null | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 33: Sarcoma - Muscle contraction | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 39: Testis - Nuclear processes | Tissue enriched | Detected in some | 14 | Cancer enriched | Detected in some | 26 | Not detected | Not detected | null | Cell type enriched | Detected in some | 4 | Group enriched | Detected in some | 4 | 0 | 0 | 0 | [] | [] | [] | 10,068 | 4 |
ENSG00000158526 | TSR2 | TSR2 ribosome maturation factor | [
"Q969E8"
] | X | 54440404-54448032 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA030514"
] | [
"DT1P1A10",
"RP1-112K5.2",
"WGG1"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"rRNA processing"
] | [] | [
"Diamond-Blackfan anemia",
"Disease variant"
] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 24 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 19: Astrocytes - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 97: Non-specific - Cellular respiration | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,069 | 9 |
ENSG00000158528 | PPP1R9A | Protein phosphatase 1 regulatory subunit 9A | [
"Q9ULJ8"
] | 7 | 94907202-95296415 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027726",
"HPA075591"
] | [
"FLJ20068",
"KIAA1222",
"Neurabin-I"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Neurogenesis"
] | [
"Actin-binding",
"Developmental protein"
] | [] | [
"Plasma membrane"
] | [] | [] | [] | Approved | Approved | null | 12 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 33: Neurons - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 9 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,070 | 3 |
ENSG00000158545 | ZC3H18 | Zinc finger CCCH-type containing 18 | [
"Q86VM9"
] | 16 | 88570403-88631964 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040847",
"HPA041327"
] | [
"NHN1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Enhanced | Enhanced | null | 168 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 16: Non-specific - Transcription | Cluster 68: Non-specific - Cell cycle regulation | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,071 | 4 |
ENSG00000158552 | ZFAND2B | Zinc finger AN1-type containing 2B | [
"Q8WV99"
] | 2 | 219195237-219209651 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035159",
"HPA035160"
] | [
"AIRAPL"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoli",
"Nucleoli rim"
] | [
"Nucleoplasm",
"Nuclear bodies",
"Primary cilium",
"Primary cilium tip",
"Basal body",
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 18 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 6: Non-specific - Immune response | Cluster 35: RS4;11 - Unknown function | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 10,072 | 8 |
ENSG00000158553 | POM121L2 | POM121 transmembrane nucleoporin like 2 | [
"Q96KW2"
] | 6 | 27285903-27312273 | Evidence at protein level | Evidence at transcript level | No human protein/transcript evidence | Evidence at protein level | [
"HPA046150"
] | [
"POM121-L"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | null | Cluster 47: Leukemia - Hemostasis | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in single | 71 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,073 | 9 |
ENSG00000158560 | DYNC1I1 | Dynein cytoplasmic 1 intermediate chain 1 | [
"O14576"
] | 7 | 95772506-96110322 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA061689"
] | [
"DNCI1",
"DNCIC1"
] | [
"Predicted intracellular proteins"
] | [
"Transport"
] | [
"Motor protein"
] | [] | [] | [] | [] | [] | null | Enhanced | Supported | 26 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 1: Neurons - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 0 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 10,075 | 8 |
ENSG00000158571 | PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | [
"P16118"
] | X | 54932961-54998534 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"PFRX"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Kinase",
"Multifunctional enzyme",
"Transferase"
] | [] | [] | [] | [] | [] | null | null | null | 13 | null | null | null | Cluster 13: Oligodendrocytes - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 89: Adipocytes - Lipid metabolism | Cluster 19: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in some | 6 | Low cancer specificity | Detected in single | null | Cancer enriched | Detected in some | 9 | Group enriched | Detected in many | 6 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 10,076 | 4 |
ENSG00000158578 | ALAS2 | 5'-aminolevulinate synthase 2 | [
"P22557"
] | X | 55009055-55030977 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ALAS-E",
"ASB"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Heme biosynthesis"
] | [
"Acyltransferase",
"Transferase"
] | [
"Disease variant"
] | [] | [] | [] | [] | null | null | null | 1 | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in many | 14 | Cancer enriched | Detected in single | 55 | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 4 | Immune cell enriched | Detected in single | 6 | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,077 | 5 |
ENSG00000158604 | TMED4 | Transmembrane p24 trafficking protein 4 | [
"Q7Z7H5"
] | 7 | 44577894-44582287 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014650"
] | [
"HNLF",
"p24a3",
"p24alpha3"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Transport"
] | null | Approved | null | 15 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 55: Non-specific - Transcription | Cluster 67: Non-specific - Unknown function | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,078 | 3 |
ENSG00000158615 | PPP1R15B | Protein phosphatase 1 regulatory subunit 15B | [
"Q5SWA1"
] | 1 | 204396492-204411887 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA061088"
] | [
"FLJ14744"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Translation regulation"
] | [] | [
"Diabetes mellitus",
"Disease variant",
"Dwarfism",
"Intellectual disability"
] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | null | null | 14 | No | No | Cluster 28: Neutrophils - Unknown function | Cluster 55: Non-specific - Transcription | Cluster 45: Non-specific - Nuclear processes | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,079 | 7 |
ENSG00000158623 | COPG2 | COPI coat complex subunit gamma 2 | [
"Q9UBF2"
] | 7 | 130506238-130668748 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045712"
] | [
"2-COP"
] | [
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 59 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 39: Non-specific - Transcription | Cluster 89: Adipocytes - Lipid metabolism | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,080 | 4 |
ENSG00000158636 | EMSY | EMSY transcriptional repressor, BRCA2 interacting | [
"Q7Z589"
] | 11 | 76444923-76553031 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB012234",
"HPA050777"
] | [
"C11orf30"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Centrosome"
] | [] | [] | Supported | Supported | null | 28 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 16: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 32: Retina & Lymphoid tissues - Signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 10,081 | 1 |
ENSG00000158639 | PAGE5 | PAGE family member 5 | [
"Q96GU1"
] | X | 55220346-55224108 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA052619",
"HPA055869"
] | [
"CT16.1",
"CT16.2",
"PAGE-5"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Supported | null | 1 | null | null | Cluster 11: T-cells - Unknown function | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in some | 26 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 6 | Immune cell enhanced | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 10,082 | 9 |
ENSG00000158669 | GPAT4 | Glycerol-3-phosphate acyltransferase 4 | [
"Q86UL3"
] | 8 | 41577187-41625001 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016471"
] | [
"AGPAT6",
"DKFZp586M1819",
"LPAAT-zeta",
"TSARG7"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Acyltransferase",
"Transferase"
] | [] | [] | [] | [] | [] | null | Approved | null | 35 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 25: Non-specific - Transcription | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10,083 | 7 |
ENSG00000158683 | PKD1L1 | Polycystin 1 like 1, transient receptor potential channel interacting | [
"Q8TDX9"
] | 7 | 47740202-47948466 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA020422",
"HPA022424"
] | [
"PRO19563"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Calcium transport",
"Ion transport",
"Transport"
] | [
"Calcium channel",
"Ion channel"
] | [
"Heterotaxy"
] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 20: Myeloma - Immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 40: Non-specific - Mixed function | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,084 | 9 |
ENSG00000158691 | ZSCAN12 | Zinc finger and SCAN domain containing 12 | [
"O43309"
] | 6 | 28378955-28399747 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA006637",
"HPA007018"
] | [
"dJ29K1.2",
"KIAA0426",
"ZFP96",
"ZNF29K1",
"ZNF305",
"ZNF96"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies",
"Cytosol"
] | [] | [] | Approved | Approved | null | 20 | null | null | Cluster 32: Basophils - Transcription | Cluster 2: Neurons - Nucleosome | Cluster 28: Non-specific - Nuclear processes | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 10,085 | 3 |
ENSG00000158710 | TAGLN2 | Transgelin 2 | [
"P37802"
] | 1 | 159918107-159925507 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001925"
] | [
"HA1756",
"KIAA0120"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [
"Vesicles",
"Actin filaments",
"Basal body"
] | [] | [] | Approved | Approved | null | 25 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 44: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 47: Platelets - Hemostasis | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 6 | 0 | 6 | [] | [
"Bladder Urothelial Carcinoma",
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 10,086 | 9 |
ENSG00000158711 | ELK4 | ETS transcription factor ELK4 | [
"P28324"
] | 1 | 205597556-205632011 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028863"
] | [
"SAP1"
] | [
"Cancer-related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Uncertain | null | 4 | null | null | Cluster 24: Non-specific - Transcription | Cluster 13: Oligodendrocytes - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 4 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,087 | 8 |
ENSG00000158714 | SLAMF8 | SLAM family member 8 | [
"Q9P0V8"
] | 1 | 159826811-159837492 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067601"
] | [
"BLAME",
"CD353",
"SBBI42"
] | [
"CD markers",
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 9 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 12: Non-specific - Vasculature | Cluster 71: Lymphoma - Inflammatory response | Cluster 82: Dendritic cells - Antigen presentation | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Skin Cutaneous Melanoma"
] | [] | [
"Skin Cutaneous Melanoma"
] | 10,088 | 2 |
ENSG00000158715 | SLC45A3 | Solute carrier family 45 member 3 | [
"Q96JT2"
] | 1 | 205657851-205680509 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA019073",
"HPA019075"
] | [
"IPCA-2",
"IPCA-6",
"IPCA-8",
"PCANAP2",
"PCANAP6",
"PCANAP8",
"prostein"
] | [
"Cancer-related genes",
"Predicted membrane proteins",
"Transporters"
] | [
"Symport",
"Transport"
] | [] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 1 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 28: Oligodendrocytes - Mixed function | Cluster 49: HMC-1 - Innate immune response | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 38: Non-specific - Basic cellular processes | Tissue enriched | Detected in many | 11 | Cancer enriched | Detected in all | 7 | Cancer enriched | Detected in many | 57 | Cell type enriched | Detected in many | 7 | Immune cell enriched | Detected in single | 382 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,089 | 3 |
ENSG00000158716 | DUSP23 | Dual specificity phosphatase 23 | [
"Q9BVJ7"
] | 1 | 159780932-159782543 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028211",
"HPA045792"
] | [
"DUSP25",
"FLJ20442"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 9 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 49: Hindbrain - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,090 | 9 |
ENSG00000158747 | NBL1 | NBL1, DAN family BMP antagonist | [
"P41271"
] | 1 | 19596979-19658456 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007394",
"CAB026132"
] | [
"D1S1733E",
"DAN",
"DAND1",
"NB",
"NO3"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [
"Tumor suppressor"
] | [] | [] | [
"Secreted in other tissues"
] | [
"No annotated function"
] | null | Uncertain | null | 4 | null | null | Cluster 11: T-cells - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,092 | 6 |
ENSG00000158748 | HTR6 | 5-hydroxytryptamine receptor 6 | [
"P50406"
] | 1 | 19664875-19680966 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA068165"
] | [
"5-HT6",
"5-HT6R"
] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Uncertain | null | 12 | null | null | Cluster 11: T-cells - Unknown function | Cluster 33: Neurons - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in single | 14 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,093 | 9 |
ENSG00000158764 | ITLN2 | Intelectin 2 | [
"Q8WWU7"
] | 1 | 160945025-160954809 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA006683",
"HPA067326"
] | [
"HL-2"
] | [
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Secreted to digestive system"
] | [
"No annotated function"
] | null | Enhanced | null | 50 | null | null | null | null | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 15: Non-specific - Protein processing | Cluster 7: Small intestine - Absorption and Digestion | Tissue enriched | Detected in some | 35 | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Cell type enriched | Detected in some | 49 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,094 | 8 |
ENSG00000158769 | F11R | F11 receptor | [
"Q9Y624"
] | 1 | 160995211-161021343 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004671",
"HPA043616",
"HPA061700"
] | [
"CD321",
"JAM-1",
"JAM-A",
"JAM1",
"JAMA",
"JCAM",
"PAM-1"
] | [
"CD markers",
"Plasma proteins",
"Predicted membrane proteins"
] | [
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [] | [
"Microtubules"
] | [
"Cell Junctions"
] | [] | [] | Supported | Enhanced | null | 30 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 12: Non-specific - Vasculature | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 4 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,095 | 1 |
ENSG00000158773 | USF1 | Upstream transcription factor 1 | [
"P22415"
] | 1 | 161039251-161045977 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001480",
"HPA036233",
"HPA036535",
"HPA068527"
] | [
"bHLHb11",
"MLTFI",
"UEF"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 34 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 14: Neurons - Synaptic function | Cluster 45: Non-specific - Nuclear processes | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | 10,096 | 3 |
ENSG00000158786 | PLA2G2F | Phospholipase A2 group IIF | [
"Q9BZM2"
] | 1 | 20139323-20150381 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [
"Immunity",
"Innate immunity",
"Lipid degradation",
"Lipid metabolism"
] | [
"Hydrolase"
] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Immunity"
] | null | null | null | null | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 58: Skin - Keratinization | Group enriched | Detected in some | 24 | Cancer enriched | Detected in single | 7 | Cancer enriched | Detected in some | 20 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Bladder Urothelial Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma"
] | 10,097 | 5 |
ENSG00000158792 | SPATA2L | Spermatogenesis associated 2 like | [
"Q8IUW3"
] | 16 | 89696357-89701705 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041182",
"HPA042453"
] | [
"C16orf76",
"MGC26885",
"tamo"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Mitochondria"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 19 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 51: Neurons - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 10,098 | 2 |
ENSG00000158793 | NIT1 | Nitrilase 1 | [
"Q86X76"
] | 1 | 161118086-161125445 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006656",
"HPA006657"
] | [] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Mitochondria",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 29: Non-specific - Unknown function | Cluster 44: Non-specific - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 10,099 | 5 |
ENSG00000158796 | DEDD | Death effector domain containing | [
"O75618"
] | 1 | 161120974-161132688 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA064486",
"HPA065101",
"HPA073628"
] | [
"CASP8IP1",
"DEDD1",
"DEFT",
"FLDED1",
"KE05"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 8 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 6: Non-specific - Immune response | Cluster 45: Non-specific - Nuclear processes | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 10,100 | 6 |
ENSG00000158805 | ZNF276 | Zinc finger protein 276 | [
"Q8N554"
] | 16 | 89720400-89740925 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA021309",
"HPA022255"
] | [
"CENP-Z",
"CENPZ",
"MGC45417",
"ZADT",
"ZFP276",
"ZNF477"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Nucleoli",
"Plasma membrane"
] | [] | [] | Approved | Uncertain | null | 9 | null | null | Cluster 24: Non-specific - Transcription | Cluster 6: Non-specific - Immune response | Cluster 68: Non-specific - Cell cycle regulation | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10,101 | 5 |
ENSG00000158806 | NPM2 | Nucleophosmin/nucleoplasmin 2 | [
"Q86SE8"
] | 8 | 22024125-22036897 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041070"
] | [] | [
"Predicted intracellular proteins"
] | [
"Fertilization"
] | [
"Chaperone",
"Chromatin regulator",
"Developmental protein"
] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | Enhanced | null | 9 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 53: Neurons - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 109: Neurons - Neuronal signaling | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | 10,102 | 5 |
ENSG00000158813 | EDA | Ectodysplasin A | [
"Q92838"
] | X | 69616067-70039472 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037972",
"HPA037973"
] | [
"ED1",
"ED1-A1",
"ED1-A2",
"EDA-A1",
"EDA-A2",
"EDA1",
"EDA2",
"HED",
"ODT1",
"XHED",
"XLHED"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Differentiation"
] | [
"Cytokine",
"Developmental protein"
] | [
"Disease variant",
"Ectodermal dysplasia"
] | [
"Vesicles"
] | [
"Lipid droplets"
] | [
"Secreted - unknown location"
] | [
"Cytokine"
] | Supported | null | null | 24 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 11: Neuronal - Sensory perception | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 4: Adrenal gland - Steroid metabolism | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,103 | 1 |
ENSG00000158815 | FGF17 | Fibroblast growth factor 17 | [
"O60258"
] | 8 | 22042398-22048809 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA052600"
] | [
"FGF-13"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted secreted proteins",
"RAS pathway related proteins"
] | [] | [
"Developmental protein",
"Growth factor"
] | [
"Cancer-related genes",
"Disease variant",
"Hypogonadotropic hypogonadism",
"Kallmann syndrome"
] | [] | [] | [
"Secreted in brain"
] | [
"Growth factor"
] | null | Uncertain | null | 1 | null | null | null | Cluster 37: Neurons - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 109: Neurons - Neuronal signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in many | 14 | Not detected | Not detected | null | Group enriched | Detected in some | 9 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,104 | 3 |
ENSG00000158816 | VWA5B1 | Von Willebrand factor A domain containing 5B1 | [
"Q5TIE3"
] | 1 | 20290875-20359518 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027496",
"HPA028405",
"HPA064829"
] | [
"FLJ32784"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Secreted in male reproductive system"
] | [
"No annotated function"
] | Approved | Enhanced | null | null | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 11: Neuronal - Sensory perception | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Cancer enriched | Detected in single | 8 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,105 | 5 |
ENSG00000158825 | CDA | Cytidine deaminase | [
"P32320"
] | 1 | 20589086-20618903 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA064202"
] | [
"CDD"
] | [
"Enzymes",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [
"FDA approved drug targets"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 19 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 11: Esophagus - Basic cellular processes | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 2 | 1 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,106 | 8 |
ENSG00000158828 | PINK1 | PTEN induced kinase 1 | [
"Q9BXM7"
] | 1 | 20633458-20651511 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001931",
"CAB026191"
] | [
"BRPK",
"PARK6"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Autophagy"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Disease variant",
"Neurodegeneration",
"Parkinson disease",
"Parkinsonism",
"Primary mitochondrial disease"
] | [] | [] | [] | [] | null | Uncertain | null | 195 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 19: Astrocytes - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 10,107 | 8 |
ENSG00000158856 | DMTN | Dematin actin binding protein | [
"Q08495"
] | 8 | 22048995-22082527 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024290",
"HPA058487"
] | [
"DMT",
"EPB49"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Actin capping",
"Actin-binding"
] | [
"Tumor suppressor"
] | [] | [] | [] | [] | null | Uncertain | null | 17 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 53: Neurons - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 78: Brain - Neuronal signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Group enriched | Detected in many | 4 | Group enriched | Detected in many | 8 | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,109 | 6 |
ENSG00000158859 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | [
"O75173"
] | 1 | 161184302-161199054 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025876",
"HPA051296",
"HPA068374"
] | [
"ADAMTS-2",
"ADMP-1",
"KIAA0688"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins",
"Predicted secreted proteins",
"Transporters"
] | [] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Enzyme"
] | Supported | Uncertain | null | 30 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 30: White matter - Myelination | Cluster 69: Skin cancer - ECM organization | Cluster 103: Non-specific - Basic cellular processes | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in single | 10 | 5 | 0 | 5 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma",
"Thyroid Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma",
"Thyroid Carcinoma"
] | 10,110 | 7 |
ENSG00000158863 | FHIP2B | FHF complex subunit HOOK interacting protein 2B | [
"Q86V87"
] | 8 | 22089150-22104911 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA025040"
] | [
"FAM160B2",
"FLJ21801",
"RAI16"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 3 | null | null | Cluster 24: Non-specific - Transcription | Cluster 18: Non-specific - Mixed function | Cluster 40: Non-specific - Unknown function | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 10,111 | 4 |
ENSG00000158864 | NDUFS2 | NADH:ubiquinone oxidoreductase core subunit S2 | [
"O75306"
] | 1 | 161197104-161214723 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA055140",
"HPA061953"
] | [
"CI-49"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Electron transport",
"Respiratory chain",
"Transport"
] | [
"Oxidoreductase",
"Translocase"
] | [
"Disease variant",
"Leber hereditary optic neuropathy",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [
"Calyx",
"Connecting piece"
] | [] | [] | Approved | Enhanced | null | 68 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 45: Non-specific - Nuclear processes | Cluster 17: Non-specific - RNA processing | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10,112 | 1 |
ENSG00000158865 | SLC5A11 | Solute carrier family 5 member 11 | [
"Q8WWX8"
] | 16 | 24845841-24911628 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035331"
] | [
"KST1",
"SGLT6",
"SMIT2"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Apoptosis",
"Ion transport",
"Sodium transport",
"Sugar transport",
"Symport",
"Transport"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 1 | null | null | null | Cluster 30: White matter - Myelination | Cluster 50: Lymphoma - Unknown function | Cluster 80: Oligodendrocytes - Myelination | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in some | 10 | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in single | null | Cell type enriched | Detected in some | 9 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,113 | 1 |
ENSG00000158869 | FCER1G | Fc epsilon receptor Ig | [
"P30273"
] | 1 | 161215234-161220699 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB022108",
"HPA026872"
] | [
"FcepsilonRIgamma"
] | [
"FDA approved drug targets",
"Predicted membrane proteins"
] | [
"Immunity",
"Innate immunity"
] | [
"IgE-binding protein",
"Receptor"
] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Supported | null | 5 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 71: Lymphoma - Inflammatory response | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,114 | 6 |
ENSG00000158874 | APOA2 | Apolipoprotein A2 | [
"P02652"
] | 1 | 161222292-161223631 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025885",
"HPA072575"
] | [] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins",
"Transporters"
] | [
"Host-virus interaction",
"Lipid transport",
"Transport"
] | [] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted to blood"
] | [
"Apolipoprotein"
] | null | Supported | null | 27 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 12: Non-specific - Vasculature | Cluster 18: Liver cancer - Metabolism | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in many | 1,359 | Cancer enriched | Detected in some | 9 | Cancer enriched | Detected in many | 314 | Cell type enriched | Detected in some | 164 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,115 | 8 |
ENSG00000158882 | TOMM40L | Translocase of outer mitochondrial membrane 40 like | [
"Q969M1"
] | 1 | 161225939-161230746 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA051304"
] | [
"FLJ12770",
"TOMM40B"
] | [
"Predicted intracellular proteins"
] | [
"Ion transport",
"Protein transport",
"Transport"
] | [
"Porin"
] | [] | [] | [] | [] | [] | null | Approved | null | null | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 45: Non-specific - Nuclear processes | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10,116 | 6 |
ENSG00000158887 | MPZ | Myelin protein zero | [
"P25189"
] | 1 | 161304735-161309968 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA068925"
] | [
"CMT1",
"CMT1B",
"CMT2I",
"CMT2J",
"HMSNIB",
"P0"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [
"Charcot-Marie-Tooth disease",
"Deafness",
"Dejerine-Sottas syndrome",
"Disease variant",
"Neurodegeneration",
"Neuropathy"
] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 7: Non-specific - Ribosome | Cluster 69: Skin cancer - ECM organization | Cluster 61: Schwann cells & Melanocytes - Mixed function | Cluster 74: Non-specific - Signal transduction | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Cancer enriched | Detected in many | 10 | Cell type enriched | Detected in many | 12 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 10,117 | 7 |
ENSG00000158901 | WFDC8 | WAP four-disulfide core domain 8 | [
"Q8IUA0"
] | 20 | 45551153-45579326 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA042710",
"HPA071119"
] | [
"C20orf170",
"dJ461P17.1",
"WAP8"
] | [
"Predicted secreted proteins"
] | [] | [
"Protease inhibitor",
"Serine protease inhibitor"
] | [] | [] | [] | [
"Secreted in male reproductive system"
] | [
"Enzyme inhibitor"
] | null | Enhanced | null | null | null | null | null | Cluster 9: Non-specific - Receptor signaling | Cluster 15: Kidney cancer - Membrane components | Cluster 30: Epididymal principal cells - Sperm storage microenvironment | Cluster 50: Epididymis - Male reproductive secretion | Tissue enriched | Detected in single | 517 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enriched | Detected in some | 27 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,118 | 1 |
ENSG00000158941 | CCAR2 | Cell cycle and apoptosis regulator 2 | [
"Q8N163"
] | 8 | 22604757-22620964 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019907",
"HPA019943",
"CAB072827",
"CAB072828"
] | [
"DBC-1",
"DBC1",
"KIAA1967",
"NET35"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Biological rhythms",
"Cell cycle",
"DNA damage",
"mRNA processing",
"mRNA splicing",
"Transcription",
"Transcription regulation",
"Wnt signaling pathway"
] | [
"Activator",
"Metalloenzyme inhibitor",
"Repressor"
] | [
"Tumor suppressor"
] | [
"Nucleoplasm",
"Nuclear bodies"
] | [] | [] | [] | Enhanced | Enhanced | null | 57 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 53: Neurons - Mixed function | Cluster 40: Non-specific - Unknown function | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 10,119 | 7 |
ENSG00000158955 | WNT9B | Wnt family member 9B | [
"O14905"
] | 17 | 46833201-46886730 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA058361",
"HPA059572"
] | [
"WNT14B",
"WNT15"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein"
] | [] | [
"Vesicles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Developmental protein"
] | Approved | Approved | null | 1 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 64: Renal epithelial cells - Ion transport & homeostasis | Cluster 69: Parathyroid gland - Mixed function | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 10 | Not detected | Not detected | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,120 | 9 |
ENSG00000158966 | CACHD1 | Cache domain containing 1 | [
"Q5VU97"
] | 1 | 64470129-64693058 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA017202"
] | [
"KIAA1573",
"VWCD1"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Calcium transport",
"Ion transport",
"Transport"
] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Uncertain | Uncertain | null | 6 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 70: DU4475 - Unknown function | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,121 | 8 |
ENSG00000158985 | CDC42SE2 | CDC42 small effector 2 | [
"Q9NRR3"
] | 5 | 131245493-131398447 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038624"
] | [
"FLJ21967",
"SPEC2"
] | [
"Predicted intracellular proteins"
] | [
"Cell shape",
"Phagocytosis"
] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 5 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 14: Neurons - Synaptic function | Cluster 55: Lymphoma - Immune response | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,122 | 9 |
ENSG00000158987 | RAPGEF6 | Rap guanine nucleotide exchange factor 6 | [
"Q8TEU7"
] | 5 | 131423921-131635231 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037982",
"HPA037983"
] | [
"PDZ-GEF2",
"PDZGEF2",
"RA-GEF-2"
] | [
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor"
] | [] | [
"Cytosol"
] | [
"Centrosome"
] | [] | [] | Approved | Approved | null | 18 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 16: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 22: Non-specific - Basic cellular functions | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,123 | 7 |
ENSG00000159055 | MIS18A | MIS18 kinetochore protein A | [
"Q9NYP9"
] | 21 | 32268228-32279049 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018286",
"HPA020585"
] | [
"B28",
"C21orf45",
"C21orf46",
"FASP1",
"hMis18alpha"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 43 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 34: Non-specific - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,125 | 4 |
ENSG00000159063 | ALG8 | ALG8 alpha-1,3-glucosyltransferase | [
"Q9BVK2"
] | 11 | 78095244-78139660 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051898"
] | [
"MGC2840"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation",
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 10 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 24: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 10,126 | 1 |
ENSG00000159069 | FBXW5 | F-box and WD repeat domain containing 5 | [
"Q969U6"
] | 9 | 136940435-136944738 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046615"
] | [
"DKFZP434B205",
"Fbw5",
"MGC20962"
] | [
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 89 | No | No | Cluster 12: Non-specific - Mitochondrial translation | Cluster 32: Cerebral cortex - Mixed function | Cluster 43: Non-specific - Basic cellular processes | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 5 | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,127 | 3 |
ENSG00000159079 | CFAP298 | Cilia and flagella associated protein 298 | [
"P57076"
] | 21 | 32592079-32612603 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018453",
"HPA019055",
"HPA028849",
"CAB034170"
] | [
"C21orf48",
"C21orf59",
"CILD26",
"DNAAF16",
"FBB18",
"FLJ20467",
"Kur"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Ciliopathy",
"Kartagener syndrome",
"Primary ciliary dyskinesia"
] | [
"Basal body",
"Cytosol",
"Principal piece"
] | [
"Nucleoplasm",
"Microtubules",
"Primary cilium transition zone",
"Centrosome"
] | [] | [] | Supported | Enhanced | null | 11 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 47: Leukemia - Hemostasis | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,128 | 3 |
ENSG00000159082 | SYNJ1 | Synaptojanin 1 | [
"O43426"
] | 21 | 32628759-32728040 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA011916"
] | [
"INPP5G",
"PARK20"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Endocytosis",
"Lipid metabolism"
] | [
"Hydrolase",
"RNA-binding"
] | [
"Disease variant",
"Epilepsy",
"Neurodegeneration",
"Parkinson disease",
"Parkinsonism"
] | [
"Nucleoplasm",
"Cytosol"
] | [
"Centrosome"
] | [] | [] | Approved | Enhanced | null | 20 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 47: Leukemia - Hemostasis | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Prostate Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Prostate Adenocarcinoma"
] | 10,129 | 8 |
ENSG00000159086 | PAXBP1 | PAX3 and PAX7 binding protein 1 | [
"Q9Y5B6"
] | 21 | 32733899-32771792 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003757"
] | [
"C21orf66",
"fSAP105",
"GCFC",
"GCFC1"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Myogenesis",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 17 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 55: Non-specific - Transcription | Cluster 56: Non-specific - Sensory perception | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,130 | 5 |
ENSG00000159110 | IFNAR2 | Interferon alpha and beta receptor subunit 2 | [
"P48551"
] | 21 | 33205282-33265675 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"IFNABR"
] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [
"Receptor"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | null | null | null | 21 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 47: Endothelial cells - Vasculature | Cluster 51: Myeloma - Immunoglobulins | Cluster 104: Brain endothelial cells - Blood brain barrier | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Rectum Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 10,131 | 4 |
ENSG00000159111 | MRPL10 | Mitochondrial ribosomal protein L10 | [
"Q7Z7H8"
] | 17 | 47823272-47831541 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA021234",
"HPA029885"
] | [
"L10MT",
"MGC17973",
"MRP-L10",
"MRP-L8",
"MRPL8",
"RPML8"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Enhanced | null | 79 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 45: Non-specific - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 41: Striated muscle - Muscle contraction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,132 | 9 |
ENSG00000159128 | IFNGR2 | Interferon gamma receptor 2 | [
"P38484"
] | 21 | 33403413-33479348 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001535"
] | [
"AF-1",
"IFNGT1"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [
"Disease variant",
"FDA approved drug targets"
] | [
"Nucleoplasm",
"Golgi apparatus"
] | [] | [] | [] | Approved | Approved | null | 28 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 12: Non-specific - Vasculature | Cluster 69: Skin cancer - ECM organization | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,133 | 3 |
ENSG00000159131 | GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | [
"P22102"
] | 21 | 33503931-33543491 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002119",
"HPA005779"
] | [
"GARS-AIRS-GART",
"PGFT",
"PRGS"
] | [
"Enzymes",
"Essential proteins",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Purine biosynthesis"
] | [
"Ligase",
"Multifunctional enzyme",
"Transferase"
] | [
"FDA approved drug targets"
] | [
"Cytosol"
] | [
"Mitochondria"
] | [] | [] | Approved | Approved | null | 15 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 17: Non-specific - RNA processing | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,134 | 9 |
ENSG00000159147 | DONSON | DNA replication fork stabilization factor DONSON | [
"Q9NYP3"
] | 21 | 33559542-33588706 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039558",
"HPA049033"
] | [
"B17",
"C21orf60",
"C2TA",
"DKFZP434M035"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Developmental protein"
] | [
"Disease variant",
"Dwarfism"
] | [
"Nucleoplasm",
"Cell Junctions"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 6 | null | null | null | Cluster 13: Oligodendrocytes - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 83: Epicardial mesothelial cells - Basic cellular functions | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 7 | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,136 | 7 |
ENSG00000159164 | SV2A | Synaptic vesicle glycoprotein 2A | [
"Q7L0J3"
] | 1 | 149903318-149917844 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002226",
"HPA007863"
] | [
"KIAA0736",
"SV2"
] | [
"FDA approved drug targets",
"Predicted membrane proteins"
] | [
"Neurotransmitter transport",
"Transport"
] | [] | [
"Disease variant",
"Epilepsy",
"FDA approved drug targets"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 7 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 109: Neurons - Neuronal signaling | Cluster 10: Brain - Synaptic signal transduction | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in many | 6 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,137 | 5 |
ENSG00000159166 | LAD1 | Ladinin 1 | [
"O00515"
] | 1 | 201380833-201399915 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007256",
"HPA028732"
] | [] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Actin filaments"
] | [] | [
"Secreted to extracellular matrix"
] | [
"No annotated function"
] | Enhanced | Enhanced | null | 6 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 10,138 | 4 |
ENSG00000159167 | STC1 | Stanniocalcin 1 | [
"P52823"
] | 8 | 23841929-23854806 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB018625",
"HPA023918"
] | [
"STC"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Hormone"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Hormone"
] | null | Approved | null | 1 | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 4 | 0 | 4 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | 10,139 | 8 |
ENSG00000159173 | TNNI1 | Troponin I1, slow skeletal type | [
"P19237"
] | 1 | 201403768-201429866 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA028190"
] | [] | [
"Predicted intracellular proteins"
] | [] | [
"Actin-binding",
"Muscle protein"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Uncertain | Approved | null | 34 | null | null | null | null | Cluster 33: Sarcoma - Muscle contraction | Cluster 55: Myocytes - Oxidative muscle function | Cluster 19: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in many | 40 | Cancer enriched | Detected in many | 9 | Group enriched | Detected in many | 7 | Cell type enriched | Detected in some | 10 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,140 | 7 |
ENSG00000159176 | CSRP1 | Cysteine and glycine rich protein 1 | [
"P21291"
] | 1 | 201483530-201509456 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA045617"
] | [
"CSRP",
"CYRP",
"D1S181E"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 6 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 19: Astrocytes - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Liver Hepatocellular Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 10,141 | 7 |
ENSG00000159182 | PRAC1 | PRAC1 small nuclear protein | [
"Q96KF2"
] | 17 | 48721719-48722518 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | [
"HPA047871"
] | [
"C17orf92",
"PRAC"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Uncertain | null | null | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 60: Prostate cancer - Unknown function | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 17: Intestine - Digestion | Group enriched | Detected in some | 11 | Cancer enriched | Detected in many | 4 | Cancer enriched | Detected in many | 4 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,142 | 3 |
ENSG00000159184 | HOXB13 | Homeobox B13 | [
"Q92826"
] | 17 | 48724763-48728750 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004438",
"HPA062852",
"HPA065019"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Enhanced | null | 3 | null | null | null | null | Cluster 60: Prostate cancer - Unknown function | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 38: Non-specific - Basic cellular processes | Group enriched | Detected in some | 12 | Cancer enriched | Detected in many | 7 | Cancer enriched | Detected in many | 11 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | 10,143 | 3 |
ENSG00000159189 | C1QC | Complement C1q C chain | [
"P02747"
] | 1 | 22643014-22648110 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001471",
"CAB009828"
] | [
"C1QG"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Complement pathway",
"Immunity",
"Innate immunity"
] | [] | [
"Disease variant"
] | [] | [] | [
"Secreted to blood"
] | [
"Complement pathway"
] | null | Supported | null | 7 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Not detected | Not detected | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 7 | Immune cell enriched | Detected in some | 6 | 0 | 0 | 0 | [] | [] | [] | 10,144 | 8 |
ENSG00000159197 | KCNE2 | Potassium voltage-gated channel subfamily E regulatory subunit 2 | [
"Q9Y6J6"
] | 21 | 34364006-34371381 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029706",
"HPA051553"
] | [
"LQT6",
"MiRP1"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted membrane proteins"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [
"Atrial fibrillation",
"Disease variant",
"Long QT syndrome"
] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | null | Cluster 1: Neurons - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 97: Non-specific - Cellular respiration | Cluster 60: Stomach - Digestion | Tissue enriched | Detected in some | 44 | Low cancer specificity | Detected in single | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 7 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | 10,145 | 8 |
ENSG00000159199 | ATP5MC1 | ATP synthase membrane subunit c locus 1 | [
"P05496"
] | 17 | 48892765-48895871 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ATP5G",
"ATP5G1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | null | null | 11 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 14: Neurons - Synaptic function | Cluster 27: Breast cancer - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 10,146 | 6 |
ENSG00000159200 | RCAN1 | Regulator of calcineurin 1 | [
"P53805"
] | 21 | 34513142-34615113 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB037218",
"HPA068436"
] | [
"DSCR1"
] | [
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 13 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 102: Non-specific - Mixed function | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 10,147 | 3 |
ENSG00000159202 | UBE2Z | Ubiquitin conjugating enzyme E2 Z | [
"Q9H832"
] | 17 | 48908407-48929056 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007922"
] | [
"FLJ13855",
"USE1"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 16 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 10,148 | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.